Zobrazeno 1 - 10
of 435
pro vyhledávání: '"E. Berezin"'
Autor:
Dmitriy Berillo, Turganova Malika, Baiken B. Baimakhanova, Amankeldi K. Sadanov, Vladimir E. Berezin, Lyudmila P. Trenozhnikova, Gul B. Baimakhanova, Alma A. Amangeldi, Bakhytzhan Kerimzhanova
Publikováno v:
Gels, Vol 10, Iss 10, p 646 (2024)
Using free microorganisms for industrial processes has some limitations, such as the extensive consumption of substrates for growth, significant sensitivity to the microenvironment, and the necessity of separation from the product and, therefore, the
Externí odkaz:
https://doaj.org/article/6758bdd417db44bbade91d28cd469ce1
Autor:
Kristen Kopp, Lukas J. Motloch, Bernhard Wernly, Alexander E. Berezin, Victoria Maringgele, Anna Dieplinger, Uta C. Hoppe, Michael Lichtenauer
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Introduction: European guidelines recommend the implementation of lipid-lowering therapies (LLTs) in adults (≥ 65 years) with established atherosclerotic cardiovascular disease (ASCVD) and for risk-based primary prevention in older adults (≤ 75 y
Externí odkaz:
https://doaj.org/article/446e62ef802140fc906a792d37b2ace4
Autor:
Elke Boxhammer, Matthias Hammerer, Christiana Schernthaner, Erika Prinz, Mathias C. Brandt, Michael Lichtenauer, Alexander E. Berezin, Wilfried Wintersteller, Uta C. Hoppe, Kristen L. Kopp
Publikováno v:
Biomedicines, Vol 12, Iss 10, p 2223 (2024)
Background: Prediabetes is frequently underdiagnosed and undertreated, yet it poses significant cardiovascular risks. This study investigates the impact of prediabetes on short- and long-term survival outcomes in patients who experienced ST-elevation
Externí odkaz:
https://doaj.org/article/fe1ae8217dc442c097c69462b2796503
Autor:
Tetiana A. Berezina, Oleksandr O. Berezin, Uta C. Hoppe, Michael Lichtenauer, Alexander E. Berezin
Publikováno v:
Biomedicines, Vol 12, Iss 8, p 1827 (2024)
The purpose of the study is to elucidate whether irisin is a promising predictive biomarker for kidney-related events in patients with T2DM and concomitant asymptomatic HF. We prospectively enrolled 146 T2DM patients who had either evidence of struct
Externí odkaz:
https://doaj.org/article/969b468911d84086a0272872ea319ae6
Autor:
Tetiana A. Berezina, Oleksandr O. Berezin, Uta C. Hoppe, Michael Lichtenauer, Alexander E. Berezin
Publikováno v:
Biomedicines, Vol 12, Iss 8, p 1857 (2024)
Adropin—a multifunctional peptide with tissue-protective capacity that regulates energy homeostasis, sensitivity to insulin and inflammatory response—seems to show an inverse association with the presence of cardiovascular and renal diseases, obe
Externí odkaz:
https://doaj.org/article/5cde7023008b4dc8ad6611129cd2351b
Autor:
Tetiana A. Berezina, Oleksandr O. Berezin, Uta C. Hoppe, Michael Lichtenauer, Alexander E. Berezin
Publikováno v:
Diagnostics, Vol 14, Iss 16, p 1728 (2024)
In patients with type 2 diabetes mellitus (T2DM), asymptomatic adverse cardiac remodeling plays a pivotal role in the development of heart failure (HF). Patients with T2DM often have low or near-normal levels of natriuretic peptides, including N-term
Externí odkaz:
https://doaj.org/article/50182004c394405ca395fa17bba14888
Autor:
Alexander E. Berezin
Publikováno v:
Cardiovascular Innovations and Applications, Vol 9, Iss 1, p 932 (2024)
Externí odkaz:
https://doaj.org/article/9fdbc8e391e64060ac76b528bfba54de
Publikováno v:
Journal of International Medical Research, Vol 52 (2024)
This narrative review was conducted due to uncertainty in predicting the beneficial impact of sodium-glucose cotransporter-2 (SGLT2) inhibitors on a dip of estimated glomerular filtration rate (eGFR), regardless of albuminuria presence, with the aim
Externí odkaz:
https://doaj.org/article/6450685ebf7d415da3c91095654868d4
Autor:
Tetiana A. Berezina, Mykola P. Kopytsya, Olga V. Petyunina, Alexander A. Berezin, Zeljko Obradovic, Lukas Schmidbauer, Michael Lichtenauer, Alexander E. Berezin
Publikováno v:
Cardiogenetics, Vol 13, Iss 1, Pp 15-30 (2023)
Cell-free nuclear (cf-nDNA) and mitochondrial (cf-mDNA) DNA are released from damaged cells in type 2 diabetes mellitus (T2DM) patients, contributing to adverse cardiac remodeling, vascular dysfunction, and inflammation. The purpose of this study was
Externí odkaz:
https://doaj.org/article/f555cc098b6e4bbaa26b3d46bf5dbbbc
Predictive value of serum irisin for chronic heart failure in patients with type 2 diabetes mellitus
Publikováno v:
Molecular Biomedicine, Vol 3, Iss 1, Pp 1-10 (2022)
Abstract We hypothesize that serum irisin can have additional discriminative potency for heart failure (HF) in individuals with type 2 diabetes mellitus (T2DM). The study group comprised 226 consecutive T2DM patients (153 patients with any HF phenoty
Externí odkaz:
https://doaj.org/article/e44af645d9944412ba6eb35d995327f7